SCHEMBL4087974

SCHEMBL4087974

CCCOC(=O)c1cc2c(o1)c(NC(=O)c1cc(C)nn1C)nn2C(=O)OCC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R8 Q9NYW2 1/20 0.35
CCNE1 P24864 2/20 0.34
CDK2 P24941 2/20 0.34
GSK3B P49841 1/20 0.34
KIFC1 Q9BW19 1/20 0.34
STING1 Q86WV6 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.33
ALDH1A1 P00352 5/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 2/20 0.32
HPGD P15428 1/20 0.32
MAOB P27338 1/20 0.32
GAA P10253 2/20 0.32
POLB P06746 2/20 0.31
BRAF P15056 1/20 0.31
CYP1A2 P05177 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4081604 0.88 ALDH1A1 (0.46) CCNE1CDK2GSK3BSMN1; SMN2NPC1
SCHEMBL4087253 0.87 CASP3 (0.38) TAS2R8KIFC1SMN1; SMN2NPC1RAB9A
SCHEMBL4091948 0.84 NPC1 (0.32) GSK3BSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL4082223 0.84 KDM4E (0.37) KIFC1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL4083862 0.83 TAS1R3 (0.38) SMN1; SMN2NPC1RAB9AKMT2AMAPT
SCHEMBL4084026 0.83 MAPT (0.42) TAS2R8SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL4078418 0.83 HTT (0.43) SMN1; SMN2NPC1RAB9AKMT2AMAPT
SCHEMBL4093454 0.83 JMJD6 (0.38) SMN1; SMN2NPC1RAB9AKMT2AMAPT
SCHEMBL4088615 0.82 KMT2A (0.45) SMN1; SMN2NPC1RAB9AKMT2AMAPT
SCHEMBL4083257 0.82 NAMPT (0.34) SMN1; SMN2NPC1RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2058315-A1 1H-Furo[3,2-C]Pyrazoles active as aurora kinase inhibitors Nerviano Medical Sciences S.r.l. (IT) 2009-05-13 EP disclosed